Target audience
The target audience includes rheumatologists, general physicians, general practitioners, specialist nurses and other specialists (e.g. ophthalmologists, dental practitioners and ENT specialists).
Areas not covered
This guideline does not cover the detailed management of patients with secondary Sjö gren's or patients with lymphoma, who should be managed in conjunction with oncologists and haematologists. The management of children is not specifically covered although is similar to that for adults with special emphasis on good dental care and hygiene.
Rigor of development and limitations
A search was undertaken for all relevant evidence from 1990 to January 2016. The level of evidence (LOE) was graded from Ia through to IV and A through to D. See Appendix 1 for full details of search criteria and LOE definitions.
A strength of agreement (SOA) was calculated for each recommendation and the results expressed as an SOA score (010) with percentage of respondents scoring the recommendation 57 in parentheses. Recommendations were only included where the mean SOA was 57 and 575% respondents scored 57. 
The guideline

Conclusion
pSS is a chronic, debilitating condition that warrants effective management. All patients should be counselled and offered topical management for sicca symptoms. Systemic treatment should be considered early in those with constitutional symptoms.
